Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jack Moses Kay Insider Profile
4 Followers
Jack Moses Kay, Director at Cannara Biotech, holds 2.19M shares in Cannara Biotech (Ticker: LOVFF), holds 418.41K shares in Helix BioPharma (Ticker: TSE:HBP). Most recently, Jack Moses Kay ― shares of Cannara Biotech on ― for an estimated value of ―.
Jack Moses Kay has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jack Moses Kay holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jack Moses Kay
Jack Moses Kay's Trading History
Cannara Biotech
―
Director
―
$1.18M
Helix BioPharma
Apr 04, 2011
Director
Informative Buy
1000.00K
C$96.23K
List of latest transactions for each holding click on a transaction to see Jack Moses Kay's performance on stock
You May Also Like
Jack Moses Kay insider profile FAQ
What is the percentage of profitable transactions made by Jack Moses Kay?
The percentage of profitable transactions made by Jack Moses Kay is ―.
What is the average return per transaction made by Jack Moses Kay?
The average return per transaction made by Jack Moses Kay is ―.
What stocks does Jack Moses Kay hold?
Jack Moses Kay holds: LOVFF, TSE:HBP stocks.
What was Jack Moses Kay’s latest transaction?
Jack Moses Kay latest transaction was an Uninformative Buy of ―.
What was Jack Moses Kay's most profitable transaction?
Jack Moses Kay’s most profitable transaction was an Informative Buy of TSE:HBP stock on April 4, 2011. The return on the trade was -44.00%.
What is Jack Moses Kay's role in Cannara Biotech?
Jack Moses Kay's role in Cannara Biotech is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.